left-caret
Insights

client alerts

Recent Developments Leave Off-Label Marketing On Shaky Ground

May 23, 2008

By Matt Martin, Ryan Lewis and Candice Voticky

The U.S. Department of Justices prosecution of pharmaceutical and medical device companies for alleged off-label marketing and the Food and Drug Administrations recent attempt to provide parameters for such marketing means that now, more than ever, pharmaceutical and medical device companies must be wary of the promotional materials they send to doctors.